Distribution and Correlates of Plasma Fibrinogen in Middle-aged Women

Author:

Stefanick Marcia L.,Legault Claudine,Tracy Russell P.,Howard George,Kessler Craig M.,Lucas Diane L.,Bush Trudy L.

Abstract

Abstract Fibrinogen levels have been reported in cohort and case-control studies to be positively related to the development of coronary heart disease. This report presents the distribution and determinants of fibrinogen in women enrolling in a 3-year randomized trial of hormone replacement therapy (HRT), the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Fasting plasma fibrinogen levels were measured in 874 postmenopausal women, aged 45 to 65 years, who had not used HRT for at least 3.5 months. Mean (±SD) fibrinogen level was 2.83±0.45 g/L. There was a significant positive association between fibrinogen and age ( P =.03). Significantly higher ( P <.005) fibrinogen levels were seen in current smokers versus nonsmokers (2.94 versus 2.81 g/L), in women who reported consuming fewer than 12 alcoholic drinks in the 12 months before the baseline visit versus higher consumption (2.90 versus 2.79 g/L), and in women who reported never versus ever having used HRT (2.90 versus 2.77 g/L). Self-reported leisure time physical activity (LTPA) was negatively associated ( P =.0001) with fibrinogen levels as follows: inactive (2.84 g/L), light (2.89 g/L), moderate (2.80 g/L), and heavy (2.60 g/L), with significantly ( P =.0001) lower levels in women who reported heavy LTPA versus each of the other categories and in women reporting moderate versus light LTPA. A strong positive correlation was found between fibrinogen and body mass index (BMI) ( r =.32; P <.0001). In a model that included age, smoking, alcohol intake, prior HRT, LTPA, and BMI, LTPA was no longer a statistically significant predictor of fibrinogen level, while associations with other variables remained significant. Fibrinogen was positively associated ( P <.001) with waist, hip, and thigh girths and waist-to-hip ratio, but these relationships were no longer significant after adjustment for BMI. In contrast, negative associations with HDL cholesterol ( r =−.25; P <.001) and positive associations with LDL cholesterol ( r =.16; P <.001) remained significant ( P <.01 and P <.05, respectively) after simultaneous adjustment for age, smoking, alcohol, prior HRT, LTPA, and BMI. Statistically significant univariate associations between fibrinogen and triglycerides, insulin and glucose levels before and after oral glucose, and blood pressure were not seen in multivariate analyses. In summary, higher fibrinogen levels were shown to be significantly and independently related to several major lifestyle and physical characteristics known to be associated with increased risk of cardiovascular disease in women.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Wenger NK Speroff L Packard B eds. Proceedings of an NHLBI Conference: Cardiovascular Health and Disease in Women. Greenwich Ct: Le Jacq Communications Inc; 1993.

2. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

3. Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction

4. Eriksson H Korsan-Bengtsen K Svardsudd WL Larsson B Tibblin G. Wilhelmsen L. 21-year follow up of CVD and total mortality among men born in 1913. In: Ernst E Koenig W Lowe GDO Meade TW eds. Fibrinogen: A ‘New’ Cardiovascular Risk Factor. Vienna Austria: Blackwell; 1992:115-119.

Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. References;Cardiovascular Disease;2018-12-28

2. Coagulation, fibrinolytic and cytokines parameters response to weight reduction in obese subjects;Electronic Journal of General Medicine;2018-01-03

3. Diet and haemostasis — A comprehensive overview;Blood Reviews;2015-07

4. Smoking increases the risk of multiple sclerosis in Queensland, Australia;Journal of Clinical Neuroscience;2014-10

5. Postmenopausal Estrogen/Progestin Interventions Trial (PEPI);Methods and Applications of Statistics in Clinical Trials;2014-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3